FASEB bioAdvances最新文献

筛选
英文 中文
In vivo optical assessment of cerebral and skeletal muscle microvascular response to phenylephrine 体内光学评估大脑和骨骼肌微血管对苯肾上腺素的反应
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-21 DOI: 10.1096/fba.2024-00063
Laura Mawdsley, Rasa Eskandari, Farah Kamar, Ajay Rajaram, Lawrence C. M. Yip, Naomi Abayomi, Stephanie Milkovich, Jeffrey J. L. Carson, Keith St. Lawrence, Christopher G. Ellis, Mamadou Diop
{"title":"In vivo optical assessment of cerebral and skeletal muscle microvascular response to phenylephrine","authors":"Laura Mawdsley,&nbsp;Rasa Eskandari,&nbsp;Farah Kamar,&nbsp;Ajay Rajaram,&nbsp;Lawrence C. M. Yip,&nbsp;Naomi Abayomi,&nbsp;Stephanie Milkovich,&nbsp;Jeffrey J. L. Carson,&nbsp;Keith St. Lawrence,&nbsp;Christopher G. Ellis,&nbsp;Mamadou Diop","doi":"10.1096/fba.2024-00063","DOIUrl":"https://doi.org/10.1096/fba.2024-00063","url":null,"abstract":"<p>This study aimed to investigate the simultaneous response of the cerebral and skeletal muscle microvasculature to the same phenylephrine (PE) boluses. A hybrid optical system that combines hyperspectral near-infrared spectroscopy (hs-NIRS) and diffuse correlation spectroscopy (DCS) was used to monitor changes in tissue oxygenation and perfusion. Data were collected from the head and hind limb of seven male Sprague–Dawley rats while administering intravenous (IV) injections of PE or saline to all animals. The response to saline was used as a control. Skeletal muscle oxygenation decreased significantly after PE injection, while a statistically underpowered decrease in perfusion was observed, followed by an increase beyond baseline. Vascular conductance also decreased in the muscle reflecting the drug's vasoconstrictive effects. Tissue oxygenation and perfusion increased in the brain in response to PE. Initially, there was a sharp increase in cerebral perfusion but no changes in cerebral vascular conductance. Subsequently, cerebral flow and vascular conductance decreased significantly below baseline, likely reflecting autoregulatory mechanisms to manage the excess flow. Further, fitting an exponential function to the secondary decrease in cerebral perfusion and increase in muscular blood flow revealed a quicker kinetic response in the brain to adjust blood flow. In the skeletal muscle, PE caused a transient decrease in blood volume due to vasoconstriction, which resulted in an overall decrease in hemoglobin content and tissue oxygen saturation. Since PE does not directly affect cerebral vessels, this peripheral vasoconstriction shunted blood into the brain, resulting in an initial increase in oxygenated hemoglobin and oxygen saturation.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00063","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human inborn errors of long-chain fatty acid oxidation show impaired inflammatory responses to TLR4-ligand LPS 人类先天性长链脂肪酸氧化错误显示出对 TLR4 配体 LPS 的炎症反应受损
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-19 DOI: 10.1096/fba.2024-00060
Signe Mosegaard, Krishna S. Twayana, Simone W. Denis, Jeffrey Kroon, Bauke V. Schomakers, Michel van Weeghel, Riekelt H. Houtkooper, Rikke K. J. Olsen, Christian K. Holm
{"title":"Human inborn errors of long-chain fatty acid oxidation show impaired inflammatory responses to TLR4-ligand LPS","authors":"Signe Mosegaard,&nbsp;Krishna S. Twayana,&nbsp;Simone W. Denis,&nbsp;Jeffrey Kroon,&nbsp;Bauke V. Schomakers,&nbsp;Michel van Weeghel,&nbsp;Riekelt H. Houtkooper,&nbsp;Rikke K. J. Olsen,&nbsp;Christian K. Holm","doi":"10.1096/fba.2024-00060","DOIUrl":"https://doi.org/10.1096/fba.2024-00060","url":null,"abstract":"<p>Stimulation of mammalian cells with inflammatory inducers such as lipopolysaccharide (LPS) leads to alterations in activity of central cellular metabolic pathways. Interestingly, these metabolic changes seem to be important for subsequent release of pro-inflammatory cytokines. This has become particularly clear for enzymes of tricarboxylic acid (TCA) cycle such as succinate dehydrogenase (<i>SDH</i>). LPS leads to inhibition of SDH activity and accumulation of succinate to enhance the LPS-induced formation of IL-1β. If enzymes involved in beta-oxidation of fatty acids are important for sufficient responses to LPS is currently not clear. Using cells from various patients with inborn long-chain fatty acid oxidation disorders (lcFAOD), we report that disease-causing deleterious variants of Electron Transfer Flavoprotein Dehydrogenase (<i>ETFDH</i>) and of Very Long Chain Acyl-CoA Dehydrogenase (<i>ACADVL</i>), both cause insufficient inflammatory responses to stimulation with LPS. The insufficiencies included reduced TLR4 expression levels, impaired TLR4 signaling, and reduced or absent induction of pro-inflammatory cytokines such as IL-6. The insufficient responses to LPS were reproduced in cells from healthy controls by targeted loss-of-function of either <i>ETFDH</i> or <i>ACADVL,</i> supporting that the deleterious <i>ETFDH</i> and <i>ACADVL</i> variants cause the attenuated responses to LPS. <i>ETFDH</i> and <i>ACADVL</i> encode two distinct enzymes both involved in fatty acid beta-oxidation, and patients with these deficiencies cannot sufficiently metabolize long-chain fatty acids. We report that genes important for beta-oxidation of long-chain fatty acids are also important for inflammatory responses to an acute immunogen trigger like LPS, which may have important implications for understanding infection and other metabolic stress induced disease pathology in lcFAODs.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Activation of nociception-sensitive ionotropic glutamate receptor-expressing rostroventrolateral medulla neurons by stimulation of cardiac afferents in rats 通过刺激大鼠心脏传入激活对痛觉敏感的离子型谷氨酸受体表达的rostroventrolateral medulla神经元
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-19 DOI: 10.1096/fba.2024-00040
Matthew R. Zahner, Cade C. Oculam, Eric Beaumont
{"title":"Activation of nociception-sensitive ionotropic glutamate receptor-expressing rostroventrolateral medulla neurons by stimulation of cardiac afferents in rats","authors":"Matthew R. Zahner,&nbsp;Cade C. Oculam,&nbsp;Eric Beaumont","doi":"10.1096/fba.2024-00040","DOIUrl":"https://doi.org/10.1096/fba.2024-00040","url":null,"abstract":"<p>Myocardial ischemia causes the release of bradykinin, which activates afferent nerve endings in the ventricular epicardium. This elicits a sympathetically mediated increase in arterial pressure and heart rate, referred to as the cardiogenic sympathetic afferent reflex. The rostroventrolateral medulla (RVLM) is a key sympathetic brain stem site for regulating cardiovascular activity. This study aimed to determine the importance of non-barosensitive nociception sympathetic activity and the role of glutamate receptor activation of RVLM neurons in the cardiogenic sympathetic afferent reflex. We tested the hypothesis that inhibition of barosensitive sympathetic activity attenuates but does not abolish the reflex response to cardiac visceral afferents. Renal sympathetic nerve activity (RSNA), arterial pressure, and heart rate responses to epicardial bradykinin application were recorded in anesthetized rats before and after bilateral RVLM microinjection of either GABA<sub>A</sub> agonist muscimol, ionotropic glutamate receptor antagonist kynurenic acid, N-methyl-d-aspartate (NMDA) receptor antagonist 2-amino-5- phosphonopentanoic acid (AP5), or non-NMDA antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Baroreceptor loading-induced inhibition of barosensitive activity attenuated the bradykinin-induced RSNA response (93 ± 14% increase) and tachycardia (18 ± 3 bpm). While RVLM muscimol microinjection abolished the RSNA response (1.6 ± 4.2% from baseline, 0.49 ± 0.38 μV*s), surprisingly, it did not abolish the tachycardia (27 ± 4 bpm). Kynurenic acid microinjection blocked the arterial pressure and RSNA responses, while AP5 or CNQX only attenuated the responses. These data suggest that nociception-sensitive sympathetic activity that does not appear to be barosensitive is also involved in the cardiogenic sympathetic afferent reflex. Importantly, while muscimol and kynurenic acid abolished the arterial pressure and RSNA response, neither affected the tachycardia, suggesting an alternate cardiac pathway independent of RVLM.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteocalcin binds to a GPRC6A Venus fly trap allosteric site to positively modulate GPRC6A signaling 骨钙素与 GPRC6A 金星蝇诱捕器异构位点结合,积极调节 GPRC6A 信号传导
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-14 DOI: 10.1096/fba.2024-00025
Rupesh Agarwal, Ruisong Ye, Micholas Dean Smith, Jeremy C. Smith, L. Darryl Quarles, Min Pi
{"title":"Osteocalcin binds to a GPRC6A Venus fly trap allosteric site to positively modulate GPRC6A signaling","authors":"Rupesh Agarwal,&nbsp;Ruisong Ye,&nbsp;Micholas Dean Smith,&nbsp;Jeremy C. Smith,&nbsp;L. Darryl Quarles,&nbsp;Min Pi","doi":"10.1096/fba.2024-00025","DOIUrl":"https://doi.org/10.1096/fba.2024-00025","url":null,"abstract":"<p>GPRC6A, a member of the Family C G-protein coupled receptors, regulates energy metabolism and sex hormone production and is activated by diverse ligands, including cations, L-amino acids, the osteocalcin (Ocn) peptide and the steroid hormone testosterone. We sought a structural framework for the ability of multiple distinct classes of ligands to active GPRC6A. We created a structural model of GPRC6A using Alphafold2. Using this model we explored a putative orthosteric ligand binding site in the bilobed Venus fly trap (VFT) domain of GPRC6A and two positive allosteric modulator (PAM) sites, one in the VFT and the other in the 7 transmembrane (7TM) domain. We provide evidence that Ocn peptides act as a PAM for GPRC6A by binding to a site in the VFT that is distinct from the orthosteric site for calcium and L-amino acids. In agreement with this prediction, alternatively spliced GPRC6A isoforms 2 and 3, which lack regions of the VFT, and mutations in the computationally predicted Ocn binding site, K352E and H355P, prevent Ocn activation of GPRC6A. These observations explain how dissimilar ligands activate GPRC6A and set the stage to develop novel molecules to activate and inhibit this previously poorly understood receptor.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
G protein coupled receptor in apoptosis and apoptotic cell clearance 细胞凋亡和凋亡细胞清除中的 G 蛋白偶联受体
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-06 DOI: 10.1096/fba.2024-00067
Xinyan Li, Chao Li, Yang Kang, Rui Zhang, Peiyao Li, Qian Zheng, Hui Wang, Hui Xiao, Lei Yuan
{"title":"G protein coupled receptor in apoptosis and apoptotic cell clearance","authors":"Xinyan Li,&nbsp;Chao Li,&nbsp;Yang Kang,&nbsp;Rui Zhang,&nbsp;Peiyao Li,&nbsp;Qian Zheng,&nbsp;Hui Wang,&nbsp;Hui Xiao,&nbsp;Lei Yuan","doi":"10.1096/fba.2024-00067","DOIUrl":"https://doi.org/10.1096/fba.2024-00067","url":null,"abstract":"<p>Apoptosis is a genetically programmed form of cell death that is substantially conserved across the evolutionary tree. Apoptotic cell elimination includes recognition, phagocytosis, and degradation. Failure to clear apoptotic cells can ultimately cause a series of human diseases, such as systemic lupus erythematosus, Alzheimer's disease, atherosclerosis, and cancer. Consequently, the timely and effective removal of apoptotic cells is crucial to maintaining the body's homeostasis. GPCRs belong to the largest membrane receptor family. Its intracellular domain exerts an effect on the trimer G protein. By combining with a variety of ligands, the extracellular domain of G protein initiates the dissociation of G protein trimers and progressively transmits signals downstream. Presently, numerous G protein-coupled receptors (GPCRs) have been identified as participants in the apoptosis signal transduction pathway and the apoptotic cell clearance pathway. Therefore, studies on the mechanism of GPCRs in the clearance of apoptotic cells is important for the development of GPCRs therapeutics.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00067","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights on pathophysiology of hydrocephalus rats induced by kaolin injection 高岭土注射诱发脑积水大鼠病理生理学的启示
IF 2.5
FASEB bioAdvances Pub Date : 2024-08-01 DOI: 10.1096/fba.2024-00070
Kuo Zhang, Wanqi Zhou, Huijie Yu, Meijun Pang, Huixin Gao, Faheem Anwar, Kai Yu, Ziwei Zhou, Fang Guo, Xiuyun Liu, Dong Ming
{"title":"Insights on pathophysiology of hydrocephalus rats induced by kaolin injection","authors":"Kuo Zhang,&nbsp;Wanqi Zhou,&nbsp;Huijie Yu,&nbsp;Meijun Pang,&nbsp;Huixin Gao,&nbsp;Faheem Anwar,&nbsp;Kai Yu,&nbsp;Ziwei Zhou,&nbsp;Fang Guo,&nbsp;Xiuyun Liu,&nbsp;Dong Ming","doi":"10.1096/fba.2024-00070","DOIUrl":"https://doi.org/10.1096/fba.2024-00070","url":null,"abstract":"<p>Hydrocephalus can affect brain function and motor ability. Current treatments mostly involve invasive surgeries, with a high risk of postoperative infections and failure. A successful animal model plays a significant role in developing new treatments for hydrocephalus. Hydrocephalus was induced in Sprague–Dawley rats by injecting 25% kaolin into the subarachnoid space at the cerebral convexities with different volumes of 30, 60 and 90 μL. Magnetic resonance imaging (MRI) was performed 1 month and 4 months after kaolin injection. The behavioral performance was assessed weekly, lasting for 7 weeks. The histopathological analyses were conducted to the lateral ventricles by hematoxylin–eosin (HE) staining. Transcriptomic analysis was used between Normal Pressure Hydrocephalus (NPH) patients and hydrocephalus rats. MRI showed a progressive enlargement of ventricles in hydrocephalus group. Kaolin-60 μL and kaolin-90 μL groups showed larger ventricular size, higher anxiety level, bigger decline in body weight, motor ability and cognitive competence. These symptoms may be due to higher-grade inflammatory infiltrate and the damage of the structure of ependymal layer of the ventricles, indicated by HE staining. The overlap upregulated genes and pathways mainly involve immunity and inflammation. Transcriptomic revealed shared pathogenic genes CD40, CD44, CXCL10, and ICAM1 playing a dominance role. 60 μL injection might be recommended for the establishment of hydrocephalus animal model, with a high successful rate and high stability. The hydrocephalus model was able to resemble the inflammatory mechanism and behavioral performance observed in human NPH patients, providing insights for identifying therapeutic targets for hydrocephalus.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00070","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene expression analysis identifies hub genes and pathways distinguishing fatal from survivor outcomes of Ebola virus disease 基因表达分析确定了区分埃博拉病毒病致死与存活结果的枢纽基因和通路
IF 2.5
FASEB bioAdvances Pub Date : 2024-07-29 DOI: 10.1096/fba.2024-00055
Melvin Mensah-Bonsu, Christopher Doss, Clay Gloster, Perpetua Muganda
{"title":"Gene expression analysis identifies hub genes and pathways distinguishing fatal from survivor outcomes of Ebola virus disease","authors":"Melvin Mensah-Bonsu,&nbsp;Christopher Doss,&nbsp;Clay Gloster,&nbsp;Perpetua Muganda","doi":"10.1096/fba.2024-00055","DOIUrl":"https://doi.org/10.1096/fba.2024-00055","url":null,"abstract":"<p>The Ebola virus poses a severe public health threat, yet understanding factors influencing disease outcomes remains incomplete. Our study aimed to identify critical pathways and hub genes associated with fatal and survivor Ebola disease outcomes. We analyzed differentially expressed hub genes (DEGs) between groups with fatal and survival outcomes, as well as a healthy control group. We conducted additional analysis to determine the functions and pathways associated with these DEGs. We found 13,198 DEGs in the fatal and 12,039 DEGs in the survival group compared to healthy controls, and 1873 DEGs in the acute fatal and survivor groups comparison. Upregulated DEGs in the comparison between the acute fatal and survivor groups were linked to ECM receptor interaction, complement and coagulation cascades, and PI3K-Akt signaling. Upregulated hub genes identified from the acute fatal and survivor comparison (FGB, C1QA, SERPINF2, PLAT, C9, SERPINE1, F3, VWF) were enriched in complement and coagulation cascades; the downregulated hub genes (IL1B, 1L17RE, XCL1, CXCL6, CCL4, CD8A, CD8B, CD3D) were associated with immune cell processes. Hub genes CCL2 and F2 were unique to fatal outcomes, while CXCL1, HIST1H4F, and IL1A were upregulated hub genes unique to survival outcomes compared to healthy controls. Our results demonstrate for the first time the association of EVD outcomes to specific hub genes and their associated pathways and biological processes. The identified hub genes and pathways could help better elucidate Ebola disease pathogenesis and contribute to the development of targeted interventions and personalized treatment for distinct EVD outcomes.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00055","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mouse developmental defects, but not paraganglioma tumorigenesis, upon conditional Complex II loss in early Sox10+ cells 早期 Sox10+ 细胞中条件性复合体 II 缺失会导致小鼠发育缺陷,但不会导致副神经节瘤肿瘤发生
IF 2.5
FASEB bioAdvances Pub Date : 2024-07-24 DOI: 10.1096/fba.2024-00056
Elizabeth P. Lewis, Fatimah Al Khazal, Brandon Wilbanks, Naomi M. Gades, Patricia Ortega-Sáenz, José López-Barneo, Igor Adameyko, L. James Maher III
{"title":"Mouse developmental defects, but not paraganglioma tumorigenesis, upon conditional Complex II loss in early Sox10+ cells","authors":"Elizabeth P. Lewis,&nbsp;Fatimah Al Khazal,&nbsp;Brandon Wilbanks,&nbsp;Naomi M. Gades,&nbsp;Patricia Ortega-Sáenz,&nbsp;José López-Barneo,&nbsp;Igor Adameyko,&nbsp;L. James Maher III","doi":"10.1096/fba.2024-00056","DOIUrl":"10.1096/fba.2024-00056","url":null,"abstract":"<p>In humans, loss of heterozygosity for defective alleles of any of the four subunits of mitochondrial tricarboxylic acid cycle enzyme succinate dehydrogenase (SDH, also Complex II of the electron transport chain) can lead to paraganglioma tumors in neuroendocrine cells. With the goal of developing mouse models of this rare disorder, we have developed various SDH conditional loss strategies. Based on recent lineage tracing studies, we hypothesized that conditional SDHC loss in early embryogenesis during migration of primordial neural crest cells that form the susceptible chromaffin cells of the adrenal medulla might induce paraganglioma. We triggered low levels of detectable SDHC loss in Sox10<sup>+</sup> cells at E11.5 of mouse development. We report that, rather than developing adrenal medulla paraganglioma (pheochromocytoma), offspring survived with evidence of neural crest cell dysfunction. Phenotypes included mild lower extremity gait anomalies suggestive of neural tube closure defects and patches of unpigmented fur consistent with neural crest-derived melanocyte dysfunction. These defects were not observed in mice lacking <i>Sdhc</i> knockout. Our results add to existing data suggesting that, unlike humans, even early embryonic (Sox10-driven) SDHx loss is inadequate to trigger paraganglioma in mice of the genetic backgrounds that have been investigated. Instead, low levels of tricarboxylic acid cycle-deficient neural crest cells cause mild developmental defects in hind limb and melanocyte function. This new model may be of interest for studies of metabolism during early neural crest cell development.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00056","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141808605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction of pathological retinal neovascularization, vessel obliteration, and artery tortuosity by PEDF protein in an oxygen-induced ischemic retinopathy rat model 在氧气诱导的缺血性视网膜病变大鼠模型中,PEDF 蛋白可减少病理性视网膜新生血管、血管阻塞和动脉迂曲
IF 2.5
FASEB bioAdvances Pub Date : 2024-07-19 DOI: 10.1096/fba.2024-00059
Shiying Zhao, Alexander V. Tschulakow, Subha S. Karthikeyan, Kun Wang, Stefan Kochanek, Ulrich Schraermeyer, Sylvie Julien-Schraermeyer
{"title":"Reduction of pathological retinal neovascularization, vessel obliteration, and artery tortuosity by PEDF protein in an oxygen-induced ischemic retinopathy rat model","authors":"Shiying Zhao,&nbsp;Alexander V. Tschulakow,&nbsp;Subha S. Karthikeyan,&nbsp;Kun Wang,&nbsp;Stefan Kochanek,&nbsp;Ulrich Schraermeyer,&nbsp;Sylvie Julien-Schraermeyer","doi":"10.1096/fba.2024-00059","DOIUrl":"10.1096/fba.2024-00059","url":null,"abstract":"<p>Retinopathy of prematurity (ROP) is a severe retinal disease in premature infants characterized by pathological neovascularization, obliteration of retinal vessels and increased vessel tortuosity. Currently, there are no completely satisfactory treatments for ROP. Pigment epithelium-derived factor (PEDF), a potent inhibitor of angiogenesis, appears late in gestation and its deficiency may be linked to development of ROP. This study investigates the preclinical efficacy of PEDF protein alone or in combination with VEGF antagonists for treating ROP. The safety of PEDF protein in the rat eye was assessed using functional in vivo measurements and histology. The efficacy of intravitreal injections (IVI) of various treatments was evaluated in a rat oxygen-induced retinopathy (OIR) model using in vivo imaging and flatmount analyses. No functional or histological side-effects were found in rat eyes after intravitreal PEDF protein injection. PEDF protein alone or combined with anti-VEGF drugs significantly reduced pathological neovascularization and vessel obliteration, comparable to the effects of anti-VEGF drugs alone. Regarding arterial tortuosity, treatment with a combination of PEDF, and VEGF antagonist was more effective than treatment with anti-VEGF alone. IVI of PEDF protein is safe. PEDF protein alone or combined with VEGF antagonists shows similar efficacy in reducing pathological neovascularization and vessel obliteration as anti-VEGF agents. Furthermore, only treatments involving PEDF protein, alone or with VEGF antagonists, significantly improved the quality of retinal vasculature. Thus, PEDF protein alone or combined with anti-VEGF agents presents a promising alternative to current anti-VEGF treatments for ROP.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00059","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative stress mediates nucleocytoplasmic shuttling of KPNA2 via AKT1-CDK1 axis-regulated S62 phosphorylation 氧化应激通过AKT1-CDK1轴调控的S62磷酸化介导KPNA2的核细胞质穿梭运动
IF 2.5
FASEB bioAdvances Pub Date : 2024-07-05 DOI: 10.1096/fba.2024-00078
Jie-Xin Huang, Chun-I Wang, Chia-Yu Kuo, Ting-Wei Chang, Yu-Chin Liu, Ting-Feng Hsiao, Chih-Liang Wang, Chia-Jung Yu
{"title":"Oxidative stress mediates nucleocytoplasmic shuttling of KPNA2 via AKT1-CDK1 axis-regulated S62 phosphorylation","authors":"Jie-Xin Huang,&nbsp;Chun-I Wang,&nbsp;Chia-Yu Kuo,&nbsp;Ting-Wei Chang,&nbsp;Yu-Chin Liu,&nbsp;Ting-Feng Hsiao,&nbsp;Chih-Liang Wang,&nbsp;Chia-Jung Yu","doi":"10.1096/fba.2024-00078","DOIUrl":"10.1096/fba.2024-00078","url":null,"abstract":"<p>Karyopherin α 2 (KPNA2, importin α1), a transport factor shuttling between the nuclear and cytoplasmic compartments, is involved in the nuclear import of proteins and participates in cellular processes such as cell cycle regulation, apoptosis, and transcriptional regulation. However, it is still unclear which signaling regulates the nucleocytoplasmic distribution of KPNA2 in response to cellular stress. In this study, we report that oxidative stress increases nuclear retention of KPNA2 through alpha serine/threonine-protein kinase (AKT1)-mediated reduction of serine 62 (S62) phosphorylation. We first found that AKT1 activation was required for H<sub>2</sub>O<sub>2</sub>-induced nuclear accumulation of KPNA2. Immunoprecipitation and quantitative proteomic analysis revealed that the phosphorylation of KPNA2 at S62 was decreased under H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. We showed that cyclin-dependent kinase 1 (CDK1), a kinase responsible for KPNA2 S62 phosphorylation, contributes to the localization of KPNA2 in the cytoplasm. AKT1 knockdown increased KPNA2 S62 phosphorylation and inhibited CDK1 activation. Furthermore, H<sub>2</sub>O<sub>2</sub>-induced AKT1 activation promoted nuclear KPNA2 interaction with nucleophosmin 1 (NPM1), resulting in attenuation of NPM1-mediated cyclin D1 gene transcription. Thus, we infer that the AKT1-CDK1 axis regulates the nucleocytoplasmic shuttling and function of KPNA2 through spatiotemporal regulation of KPNA2 S62 phosphorylation under oxidative stress conditions.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2024-00078","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141673676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信